[VIVO] QoQ Quarter Result on 31-Mar-2017 [#Q2]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
10-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q2]
Profit Trend
QoQ- 48.30%
YoY- 2.43%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 52,283 49,697 50,140 54,125 46,809 46,998 50,665 2.11%
PBT 7,658 8,634 3,946 14,190 9,659 8,752 13,401 -31.06%
Tax 1,356 2,908 3,706 4,878 3,380 3,261 4,647 -55.90%
NP 6,302 5,726 240 9,312 6,279 5,491 8,754 -19.62%
Tax Rate -17.71% -33.68% -93.92% -34.38% -34.99% -37.26% -34.68% -
Total Cost 45,981 43,971 49,900 44,813 40,530 41,507 41,911 6.35%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin 12.05 11.52 0.48 17.20 13.41 11.68 17.28 -21.31%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS 0.15 0.14 0.01 0.22 0.15 0.13 0.21 -20.04%
EPS Diluted 0.15 0.13 0.01 0.22 0.15 0.13 0.21 -20.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.